<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2019</study_start_year><data_sharing_plan>IPD Sharing (as of January 2020): Undecided</data_sharing_plan><condition>Metastatic Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Metastatic Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2327290</full_dataset_link><location>Italy</location><study_start_month>11</study_start_month><keyword>Early detection of metastases</keyword><keyword>Liquid biopsy</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>Early Detection of Relapses in Stage IV Colorectal Cancer Patients</name><description>This study is a prospective, multicenter, observational study on metastatic, operable colorectal cancer to evaluate the proof of concept of the cfDNA analysis for the early detection of recurrences</description><dates><creation>2019-11-15</creation></dates><accession>2327290</accession><cross_references><ClinicalTrials___gov>NCT04232891</ClinicalTrials___gov></cross_references></HashMap>